Table 3. Results of multivariate Cox proportional-hazards model regarding all-cause mortality and cardiac mortality.
| Characteristics | All-Cause Mortality |
Cardiac Mortality |
||
|---|---|---|---|---|
| HR (95% CI) | p | HR (95% CI) | p | |
| Fibrinogen* | 2.01 (1.51–2.68) | <0.001 | 1.58 (1.09–2.31) | 0.016 |
| Age† | 1.54 (1.32–1.79) | <0.001 | 1.26 (1.04–1.53) | 0.018 |
| Men | 0.95 (0.70–1.30) | 0.746 | 1.05 (0.69–1.59) | 0.820 |
| Pre-hypertension | 0.95 (0.71–1.28) | 0.741 | 0.99 (0.67–1.48) | 0.975 |
| Pre-diabetes mellitus | 1.47 (1.09–1.98) | 0.011 | 1.42 (0.95–2.14) | 0.090 |
| eGFR at admission‡ | 1.29 (1.12–1.49) | 0.001 | 1.36 (1.13–1.64) | 0.001 |
| LDL-C | 1.02 (1.01–1.03) | <0.001 | 1.02 (1.01–1.03) | <0.001 |
| Diagnosis of ACS | 2.10 (1.48–2.96) | <0.001 | 2.65 (1.63–4.31) | <0.001 |
| Aspirin | 0.31 (0.21–0.45) | <0.001 | 0.30 (0.17–0.51) | <0.001 |
| Clopidogrel | 0.40 (0.27–0.60) | <0.001 | 0.30 (0.18–0.50) | <0.001 |
| Statin | 0.50 (0.35–0.73) | <0.001 | 0.50 (0.30–0.84) | 0.008 |
| ACE inhibitors or ARBs | 0.72 (0.54–0.97) | 0.033 | 0.70 (0.46–1.07) | 0.096 |
| Beta-receptor blockers | 0.57 (0.43–0.76) | <0.001 | 0.50 (0.34–0.74) | 0.001 |
*Grouped by the cut-off value 3.17 g/L; †for 10-year increase; ‡for each 30 ml/min decrease.
Abbreviations: HR, hazard ratio; CI, confidence interval; eGFR, estimated glomerular filtration rate; LDL-C, low-density lipoprotein-cholesterol; ACS, acute coronary syndrome; ACE, angiotensin-converting enzyme; ARBs, angiotensin-receptor blockers.